Ma Songjiang's most recent trade in Gyre Therapeutics Inc was a trade of 2,000 Common Stock done at an average price of $10.3 . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 27 May 2025 | 2,000 | 2,806,642 | - | 10.3 | 20,560 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 27 May 2025 | 558 | 2,806,084 | - | 10.1 | 5,619 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 22 May 2025 | 2,000 | 2,808,824 | - | 11.0 | 21,940 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 22 May 2025 | 182 | 2,808,642 | - | 10.2 | 1,864 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 20 May 2025 | 2,000 | 2,810,824 | - | 10.8 | 21,660 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 20 May 2025 | 2,000 | 2,812,824 | - | 11.3 | 22,500 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 16 May 2025 | 2,000 | 2,816,824 | - | 11.3 | 22,620 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 16 May 2025 | 2,000 | 2,814,824 | - | 11.1 | 22,220 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 14 May 2025 | 2,000 | 2,818,824 | - | 10.7 | 21,360 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 14 May 2025 | 20 | 2,820,824 | - | 11.3 | 226 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 12 May 2025 | 2,000 | 2,820,844 | - | 11.4 | 22,740 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 12 May 2025 | 2,000 | 2,822,844 | - | 10.6 | 21,120 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 21 Mar 2025 | 174 | 2,824,844 | - | 10 | 1,740 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 19 Mar 2025 | 2,000 | 2,825,018 | - | 10.1 | 20,180 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 19 Mar 2025 | 2,000 | 2,827,018 | - | 10.1 | 20,260 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 17 Mar 2025 | 2,000 | 2,829,260 | - | 12.1 | 24,180 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 17 Mar 2025 | 242 | 2,829,018 | - | 10.2 | 2,478 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 13 Mar 2025 | 2,000 | 2,831,260 | - | 12.3 | 24,620 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 13 Mar 2025 | 2,000 | 2,833,260 | - | 11.8 | 23,600 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 11 Mar 2025 | 2,000 | 2,835,260 | - | 11.7 | 23,480 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 11 Mar 2025 | 2,000 | 2,837,260 | - | 11.4 | 22,800 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 07 Mar 2025 | 2,000 | 2,839,260 | - | 10.1 | 20,280 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 07 Mar 2025 | 1,906 | 2,841,260 | - | 10.1 | 19,308 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 07 Mar 2025 | 53 | 2,843,207 | - | 13.0 | 691 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 07 Mar 2025 | 41 | 2,843,166 | - | 12.1 | 498 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 05 Mar 2025 | 2,000 | 2,843,260 | - | 10.8 | 21,600 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 05 Mar 2025 | 2,000 | 2,845,260 | - | 11.0 | 21,960 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 03 Mar 2025 | 2,000 | 2,847,260 | - | 10.9 | 21,720 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 03 Mar 2025 | 2,000 | 2,849,260 | - | 11.2 | 22,460 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 27 Feb 2025 | 2,000 | 2,851,260 | - | 11.4 | 22,820 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 27 Feb 2025 | 2,000 | 2,853,260 | - | 11.3 | 22,660 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 25 Feb 2025 | 2,000 | 2,855,260 | - | 11.6 | 23,260 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 25 Feb 2025 | 2,000 | 2,857,260 | - | 11.4 | 22,740 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 21 Feb 2025 | 1,818 | 2,861,442 | - | 11.8 | 21,525 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 21 Feb 2025 | 1,813 | 2,859,447 | - | 10.6 | 19,218 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 21 Feb 2025 | 187 | 2,859,260 | - | 11.5 | 2,154 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 21 Feb 2025 | 182 | 2,861,260 | - | 12.6 | 2,293 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 19 Feb 2025 | 2,000 | 2,863,260 | - | 12.4 | 24,800 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 19 Feb 2025 | 2,000 | 2,865,260 | - | 12.3 | 24,580 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 14 Feb 2025 | 2,000 | 2,867,260 | - | 12.5 | 24,980 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 14 Feb 2025 | 2,000 | 2,869,260 | - | 11.9 | 23,880 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 12 Feb 2025 | 2,000 | 2,871,260 | - | 11.7 | 23,380 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 12 Feb 2025 | 2,000 | 2,873,260 | - | 11.5 | 22,980 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 10 Feb 2025 | 2,000 | 2,877,138 | - | 11.9 | 23,800 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 10 Feb 2025 | 1,878 | 2,875,260 | - | 11.5 | 21,635 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 06 Feb 2025 | 2,000 | 2,879,158 | - | 12.2 | 24,320 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 06 Feb 2025 | 2,000 | 2,881,138 | - | 12.9 | 25,700 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 04 Feb 2025 | 2,000 | 2,885,138 | - | 11.6 | 23,240 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 04 Feb 2025 | 1,980 | 2,883,158 | - | 12.4 | 24,532 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 04 Feb 2025 | 20 | 2,883,138 | - | 12.9 | 257 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 31 Jan 2025 | 2,000 | 2,887,138 | - | 11.5 | 22,940 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 31 Jan 2025 | 2,000 | 2,889,138 | - | 11.5 | 23,020 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 29 Jan 2025 | 2,000 | 2,891,138 | - | 11.4 | 22,740 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 29 Jan 2025 | 2,000 | 2,893,138 | - | 11.4 | 22,860 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 27 Jan 2025 | 2,000 | 2,897,138 | - | 11.2 | 22,360 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 27 Jan 2025 | 2,000 | 2,895,138 | - | 11.5 | 23,020 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 23 Jan 2025 | 2,000 | 2,899,138 | - | 10.9 | 21,780 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 23 Jan 2025 | 2,000 | 2,901,138 | - | 10.5 | 20,980 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 21 Jan 2025 | 2,000 | 2,903,138 | - | 10.6 | 21,260 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 21 Jan 2025 | 2,000 | 2,905,138 | - | 10.9 | 21,700 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 16 Jan 2025 | 2,000 | 2,907,138 | - | 10.7 | 21,440 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 16 Jan 2025 | 2,000 | 2,909,138 | - | 10.7 | 21,420 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 14 Jan 2025 | 2,000 | 2,911,138 | - | 10.9 | 21,700 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 14 Jan 2025 | 2,000 | 2,913,138 | - | 10.4 | 20,780 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 10 Jan 2025 | 1,057 | 2,915,194 | - | 10.0 | 10,591 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 10 Jan 2025 | 56 | 2,915,138 | - | 10.1 | 566 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 06 Jan 2025 | 1,275 | 2,916,251 | - | 10.0 | 12,776 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 06 Jan 2025 | 941 | 2,917,526 | - | 10.2 | 9,561 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 02 Jan 2025 | 2,000 | 2,920,467 | - | 12.4 | 24,800 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 02 Jan 2025 | 1,167 | 2,919,300 | - | 11.0 | 12,872 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 02 Jan 2025 | 833 | 2,918,467 | - | 11.8 | 9,871 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 30 Dec 2024 | 2,000 | 2,926,467 | - | 12.6 | 25,160 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 30 Dec 2024 | 2,000 | 2,922,467 | - | 12.3 | 24,600 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 30 Dec 2024 | 2,000 | 2,924,467 | - | 12.5 | 25,000 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 30 Dec 2024 | 1,644 | 2,928,823 | - | 12.6 | 20,747 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 30 Dec 2024 | 356 | 2,928,467 | - | 13.1 | 4,646 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 23 Dec 2024 | 2,000 | 2,930,467 | - | 11.9 | 23,860 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 23 Dec 2024 | 1,704 | 2,932,763 | - | 12.2 | 20,857 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 23 Dec 2024 | 296 | 2,932,467 | - | 12.4 | 3,682 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 19 Dec 2024 | 2,000 | 2,934,467 | - | 10.9 | 21,800 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 19 Dec 2024 | 2,000 | 2,936,467 | - | 10.8 | 21,640 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 17 Dec 2024 | 1,571 | 2,938,896 | - | 11.2 | 17,548 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 17 Dec 2024 | 1,212 | 2,941,255 | - | 10.9 | 13,259 | Common Stock | |
| Gyre Therapeutics Inc | Ma Songjiang | Director, President | 17 Dec 2024 | 788 | 2,940,467 | - | 11.2 | 8,849 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 17 Dec 2024 | 429 | 2,938,467 | - | 12.1 | 5,195 | Common Stock | |
| Gyre Therapeutics Inc | Songjiang Ma | Director, President | 14 Aug 2024 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) |